AI Tools
Bio AIBeginner

Boltz API

The Boltz API is a molecular and protein design API released by Boltz PBC and the Boltz Team on June 16, 2026, enabling users to invoke the BoltzMol-1 and BoltzProt-1 models within research automation environments. BoltzMol-1 is used for small molecule generation, virtual screening, and initial hit discovery, while BoltzProt-1 handles tasks involving the design of proteins and conjugates to bind to a target. Researchers can access these capabilities via Python or TypeScript SDKs or CLI tools with their existing

The Boltz API is a molecular and protein design API released by Boltz PBC and the Boltz Team on June 16, 2026. It enables users to invoke the BoltzMol-1 and BoltzProt-1 models within research automation environments. BoltzMol-1 is used for small molecule generation, virtual screening, and initial hit discovery, while BoltzProt-1 handles tasks involving the design of proteins and complexes to bind to specific targets. Researchers can integrate these capabilities into existing analysis code via Python or TypeScript SDKs or CLI tools. Additionally, coding agents such as Codex, Claude Code, and Gemini CLI can delegate molecular and protein design tasks to the API through tool calls. Similar to how GPT converts natural language requests into executable text actions, the Boltz API serves as an interface that translates researchers’ design objectives into computable molecular and protein exploration tasks.

Existing computational drug discovery workflows often require connecting different models and scripts at each stage: structure preparation, candidate generation, scoring, and result consolidation. Even when models are open-source, utilizing them requires configuring GPU environments, managing weights, resolving dependency conflicts, and operating servers for batch execution, making immediate adoption difficult for small research teams or automation agents. The key differentiator of the Boltz API is that it wraps molecular generation and protein design models behind a remote interface, reducing operational burdens and enabling not only humans but also scientific agents to execute iterative exploration loops directly. Notably, providing models validated through experimental verification distinguishes this service from simple structure prediction services. However, specific validation data, success rates, benchmark conditions, and per-model input limitations must be verified in the official documentation.

In research applications, the API can first automate small molecule hit discovery for disease targets. For example, a researcher prepares the target and design constraints, submits a BoltzMol-1 task via the Python SDK, and then loads the returned candidates into RDKit to calculate molecular weight, cLogP, synthetic accessibility, and structural redundancy. After filtering the primary candidate pool, re-evaluating them with docking or molecular dynamics tools allows the conversion of API-generated results into an experimental priority list. The number of candidates, sampling settings, acceptable constraints, and output formats must be confirmed after reviewing the API documentation.

For protein or complex design, the results from BoltzProt-1 can be linked to structure quality assessment and experimental design stages. Researchers input the binding target and design objectives, generate multiple candidates, and then select expression test subjects by performing sequence deduplication, structural confidence review, and filtering for immunogenicity and aggregation propensity. Furthermore, assigning a coding agent the sequence of “candidate generation → result parsing → property calculation → top candidate report generation” allows repetitive design tasks to be organized into reproducible pipelines. However, before applying the API to sensitive projects, conditions regarding the storage, reuse, confidentiality, and intellectual property rights of biological data transmitted via the API must be reviewed in the Supplemental Terms.

💻 System Requirements

🧠RAM

원격 API 사용 시 로컬 GPU 불필요

💾Storage

SDK와 입력·출력 데이터 저장 공간 필요; 정확한 패키지 크기는 확인 필요

Installation

4-1. Quick Start

공식 문서에 기재된 Python·TypeScript SDK 또는 CLI 설치 명령을 사용해야 한다. 제공된 Discovery 정보에는 패키지명과 설치 명령이 포함되어 있지 않으므로 임의 명령을 제시하지 않으며, https://api.boltz.bio/docs/ 에서 최신 Quick Start를 확인해야 한다.

4-2. 상세 설치

공식 API 문서에서 계정 생성과 인증 방식, SDK 패키지명, 환경변수 설정, 모델별 요청 스키마, 작업 상태 조회 및 결과 다운로드 절차를 순서대로 확인해야 한다. 설치 명령과 API 호출 예시는 외부 검증 후 추가하는 것이 안전하다.

🧬 Bio Use Cases

🔬

🔬 Automated Small Molecule Hit Discovery

Generate candidates using BoltzMol-1, then calculate molecular weight, cLogP, and structural redundancy in RDKit. Select top candidates based on predefined physicochemical properties and pass them to docking and cell-based assay pipelines. The number of candidates and generation parameters require verification via the official API schema.

🧬

🧬 Target-Binding Protein Candidate Design

Design target-binding complex candidates using BoltzProt-1, then feed the returned sequences and structures into quality assessment tools. Narrow down targets for expression and binding assays by removing duplicate sequences and filtering for aggregation propensity. Supported input formats and candidate generation limits require verification.

💊

🤖 Agent-Based Iterative Design

Configure Codex, Claude Code, and Gemini CLI to call the Boltz API, chaining candidate generation, result parsing, RDKit property calculation, and CSV report generation. Set iteration counts, concurrent requests, and cost limits after verifying API pricing and rate limits.

FAQ

What is Boltz API?

The Boltz API is a molecular and protein design API released by Boltz PBC and the Boltz Team on June 16, 2026. It enables users to invoke the BoltzMol-1 and BoltzProt-1 models within research automation environments. BoltzMol-1 is used for small molecule generation, virtual screening, and initial hit discovery, while BoltzProt-1 handles tasks involving the design of proteins and complexes to bind to specific targets. Researchers can integrate these capabilities into existing analysis code via Python or TypeScript SDKs or CLI tools. Additionally, coding agents such as Codex, Claude Code, and Gemini CLI can delegate molecular and protein design tasks to the API through tool calls. Similar to how GPT converts natural language requests into executable text actions, the Boltz API serves as an interface that translates researchers’ design objectives into computable molecular and protein exploration tasks. Existing computational drug discovery workflows often require connecting different models and scripts at each stage: structure preparation, candidate generation, scoring, and result consolidation. Even when models are open-source, utilizing them requires configuring GPU environments, managing weights, resolving dependency conflicts, and operating servers for batch execution, making immediate adoption difficult for small research teams or automation agents. The key differentiator of the Boltz API is that it wraps molecular generation and protein design models behind a remote interface, reducing operational burdens and enabling not only humans but also scientific agents to execute iterative exploration loops directly. Notably, providing models validated through experimental verification distinguishes this service from simple structure prediction services. However, specific validation data, success rates, benchmark conditions, and per-model input limitations must be verified in the official documentation. In research applications, the API can first automate small molecule hit discovery for disease targets. For example, a researcher prepares the target and design constraints, submits a BoltzMol-1 task via the Python SDK, and then loads the returned candidates into RDKit to calculate molecular weight, cLogP, synthetic accessibility, and structural redundancy. After filtering the primary candidate pool, re-evaluating them with docking or molecular dynamics tools allows the conversion of API-generated results into an experimental priority list. The number of candidates, sampling settings, acceptable constraints, and output formats must be confirmed after reviewing the API documentation. For protein or complex design, the results from BoltzProt-1 can be linked to structure quality assessment and experimental design stages. Researchers input the binding target and design objectives, generate multiple candidates, and then select expression test subjects by performing sequence deduplication, structural confidence review, and filtering for immunogenicity and aggregation propensity. Furthermore, assigning a coding agent the sequence of “candidate generation → result parsing → property calculation → top candidate report generation” allows repetitive design tasks to be organized into reproducible pipelines. However, before applying the API to sensitive projects, conditions regarding the storage, reuse, confidentiality, and intellectual property rights of biological data transmitted via the API must be reviewed in the Supplemental Terms.

When should I use Boltz API?

The Boltz API is a molecular and protein design API released by Boltz PBC and the Boltz Team on June 16, 2026, enabling users to invoke the BoltzMol-1 and BoltzProt-1 models within research automation environments. BoltzMol-1 is used for small molecule generation, virtual screening, and initial hit discovery, while BoltzProt-1 handles tasks involving the design of proteins and conjugates to bind to a target. Researchers can access these capabilities via Python or TypeScript SDKs or CLI tools with their existing

What is a biomedical use case for Boltz API?

🔬 Automated Small Molecule Hit Discovery: Generate candidates using BoltzMol-1, then calculate molecular weight, cLogP, and structural redundancy in RDKit. Select top candidates based on predefined physicochemical properties and pass them to docking and cell-based assay pipelines. The number of candidates and generation parameters require verification via the official API schema.

📄 Official Docs🐙 GitHub

📝 Update Notes

  1. vv2.2.18/25/2026

    Boltz API v2.2.1 업데이트는 모델의 수치적 안정성과 예측 신뢰도를 높이기 위한 버그 수정에 집중했습니다. 특히 포켓 제약 조건(pocket constraints) 및 포텐셜(potentials) 관련 오류를 해결하여, 단백질-리간드 상호작용 모델링의 정확도를 개선했습니다. 또한 입력 접미사의 대소문자 구분 문제를 해결하고 데이터 처리 로직을 최적화하여, 더욱 편리하고 안정적인 구조 예측 워크플로우를 지원합니다.

🧪 Related Code of Life

No related Code of Life posts yet.